USPTO 2015–2025 USPTO PatentsView Foreign Corporation

SUN PHARMACEUTICAL INDUSTRIES LIMITED

USPTO PatentsView assignee record — 126 granted patents across 23 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

126
Total patents granted
23
CPC technology areas
13.9
Avg claims per patent
-3%
5-year filing velocity

The verdict

SUN holds 126 US patents across 23 technology areas — rank #3,025 of 50,000 tracked assignees.

#3,025
of 50,000 US assignees by volume
Top 15%
by Innovation Score (49.1/100)
13.9
avg claims per patent
-3%
filing velocity, last 5 yrs

Portfolio overview

SUN PHARMACEUTICAL INDUSTRIES LIMITED has been granted 126 US utility patents between 2015 and 2025, placing SUN PHARMACEUTICAL INDUSTRIES LIMITED at rank #3,025 across all assignees tracked by PlainPatent. This portfolio spans 23 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.9 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, SUN PHARMACEUTICAL INDUSTRIES LIMITED is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 49.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 62 grants, compared with 64 in the 2015–2019 window — a -3% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. SUN PHARMACEUTICAL INDUSTRIES LIMITED's 13.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 23 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark SUN PHARMACEUTICAL INDUSTRIES LIMITED against peers pursuing similar technology classes.

How does SUN compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows SUN holds 126 patents — placing it at rank #3,025 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

SUN's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

0510152025 20152016201720182019202020212022202320242025 9
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
SUN PHARMACEUTICAL INDUSTRIES LIMITED patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 0.8%
2016 9 7.1%
2017 21 16.7%
2018 18 14.3%
2019 15 11.9%
2020 5 4.0%
2021 13 10.3%
2022 14 11.1%
2023 4 3.2%
2024 17 13.5%
2025 9 7.1%

Which technologies does SUN PHARMACEUTICAL INDUSTRIES LIMITED patent most?

Top 15 of 23 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#3,025

Across all tracked assignees

Innovation Score

49.1 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does SUN PHARMACEUTICAL INDUSTRIES LIMITED hold?
SUN PHARMACEUTICAL INDUSTRIES LIMITED holds 126 US granted patents filed between 2015 and 2025, spanning 23 technology areas.
What is SUN PHARMACEUTICAL INDUSTRIES LIMITED's Innovation Score?
SUN PHARMACEUTICAL INDUSTRIES LIMITED has an Innovation Score of 49.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does SUN PHARMACEUTICAL INDUSTRIES LIMITED focus on?
SUN PHARMACEUTICAL INDUSTRIES LIMITED's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 99 patents. The company has filed patents in 23 CPC subclasses total.
Is SUN PHARMACEUTICAL INDUSTRIES LIMITED's patent filing rate increasing or decreasing?
SUN PHARMACEUTICAL INDUSTRIES LIMITED's recent filing velocity is -3% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for SUN PHARMACEUTICAL INDUSTRIES LIMITED's patents?
SUN PHARMACEUTICAL INDUSTRIES LIMITED's patents average 13.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the SUN PHARMACEUTICAL INDUSTRIES LIMITED patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope